Latest Breaking News On - Head of global corporate communications - Page 4 : comparemela.com

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Zwei rohstoff chancenAndrean flynnLas vegasExperte carsten storkKristin bhavnaniPrnewswire jazz pharmaceuticalsJazz pharmaceuticalsGlobal health care conference onHead of global corporate communicationsBofa securitiesHealth care conferenceGlobal corporate

Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance

– 12% year-over-year revenue increase from combined key growth drivers: Xywav®, Epidiolex® and Rylaze® –– Oncology revenues grew 13% year-over-year –– Submitted zanidatamab BLA for 2L.

Bruce cozaddEpidiolex epidyolexRedx pharmaRylaze enrylazeKristin bhavnaniAndrean flynnAccess programCompany annual report on formHead of global corporate communicationsPrnewswire jazz pharmaceuticalsEuropean medicines agencyJazz pharmaceuticalsExchange commissionTop line phaseEpidyolex phaseIdiopathic hypersomnia

Bayer and Evotec collaborate to advance precision cardiology

EQS-News: Evotec SE / Key word: Miscellaneous Bayer and Evotec collaborate to advance precision cardiology 30.04.2024 / 08:30 CET/CEST The issuer is solely responsible.

Volker braunHinnerk rohwedderChristian rommelJuergen eckhardtGabriele hansenLisa hennigHead of researchBayer pharmaceuticals divisionGlobal corporate communicationsDistribution servicesHead of global corporate communicationsBusiness developmentChief scientific officerMedia contactGlobal investor relationsCorporate news

Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth

FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCEPRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN &euro;&nbsp;40&nbsp;MEVOTEC&rsquo;S REPORTING STRUCTURE WILL CHANGE TO BUSINESS SEGMENTS &ldquo;SHARED R&D&am.

Basse normandieFrance generalMario polywkaVolker braunChristian wojczewskiBristol myers squibbEvotec biologicsGabriele hansenHinnerk rohwedderEvotec groupGlobal corporate communicationsEvotec se frankfurt stock exchangeChinese national medical products administrationHead of global corporate communicationsZhejiang jingxin pharmaceutical co ltdHealth ingredients

Evotec SE: Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth

Evotec SE: Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalBasse normandieEvotec biologicsGabriele hansenHinnerk rohwedderDennis riedlMario polywkaBristol myers squibbChristian wojczewskiVolker braunZhejiang jingxin pharmaceutical co ltdChinese national medical products administrationHealth ingredientsHead of global corporate communicationsEvotec se frankfurt stock exchangeEvotec group